Capreomycin disulfate

硫酸卷曲霉素

Report date: 2024/05/29 20:00:36
NME

Base Information

Drug NameCapreomycin disulfate
Drug Alias Name硫酸卷须霉素capreomycinumcapreomicinaCaprastat sulfateCapastat Sulfate +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRibosome subunits inhibitors
TargetsNot applicable
Therapy Area/IndicationsTuberculosis, Pulmonary
Global Approved IndicationsTuberculosis, Pulmonary
Approved Indications in ChinaTuberculosis, Pulmonary
Original Approved Country/TerritoryMainland China
Original Approved Date1996/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesHenan Taifeng Biotechnology Co LtdLiaoning Beiqi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsTuberculosis, Pulmonary
Inactive IndicationsN/A

Other Information

ATC CodeJ04AB30
Related LinksWikipediaDrugBankKEGG